Endgenitor Technologies

Developing therapies using isolated adult stem /progenitor cells obtained from umbilical cord blood.

placeIndianapolis, Indiana, United States calendar_todayFounded 2005 language endgenitor.com

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace dormant. Cited 9 times.

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon